GEN Exclusives

More »

GEN News Highlights

More »
Sep 25, 2006

DARPA funding Will Help Lexicon Genetics Identify Sleep Deprivation-Related Targets

  • Lexicon Genetics was awarded funding from DARPA for the identification of targets that will aid in developing drugs to enhance the restorative benefits derived from sleep and offset problems associated with sleep deprivation.

    “Through use of our proprietary drug target discovery platform, we have identified two genes that appear to impact the mechanism of sleep,” says Brian P. Zambrowicz, Ph.D., executive vp of research. “Our work under this grant may have application to the military and the general population.”

    Under the award, Lexicon will be investigating the molecular and cellular basis of sleep, sleep pathways, and the correlation between sleep architecture and performance, including under conditions of sleep deprivation. Lexicon will also study specific genes that alter normal sleep/wake cycles when knocked out in mice.

    Current military operations increasingly place demands for higher levels of performance without adequate provision for opportunities to rest and sleep. Identifying novel pharmaceutical approaches aimed at preventing the harmful effects of sleep deprivation may enhance the ability of military personnel to function more safely and effectively despite prolonged periods of wakefulness.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »